| Product Code: ETC8259529 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of insulin biosimilars to Mauritius in 2024 continued to be dominated by key exporters such as China, South Africa, Spain, Metropolitan France, and India. Despite a decrease in concentration compared to 2023, the market remained highly concentrated in 2024. The compound annual growth rate (CAGR) for the period 2020-2024 was notably negative at -24.51%, with a further decline in the growth rate from 2023 to 2024 at -36.04%. This data suggests a challenging market environment for insulin biosimilars in Mauritius, potentially impacted by various factors influencing trade dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Insulin Biosimilars Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Insulin Biosimilars Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Insulin Biosimilars Market - Industry Life Cycle |
3.4 Mauritius Insulin Biosimilars Market - Porter's Five Forces |
3.5 Mauritius Insulin Biosimilars Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Mauritius Insulin Biosimilars Market Revenues & Volume Share, By Indicative, 2021 & 2031F |
3.7 Mauritius Insulin Biosimilars Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Mauritius Insulin Biosimilars Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius Insulin Biosimilars Market Trends |
6 Mauritius Insulin Biosimilars Market, By Types |
6.1 Mauritius Insulin Biosimilars Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Insulin Biosimilars Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Mauritius Insulin Biosimilars Market Revenues & Volume, By Rapid-acting biosimilar, 2021- 2031F |
6.1.4 Mauritius Insulin Biosimilars Market Revenues & Volume, By Long-acting biosimilar, 2021- 2031F |
6.1.5 Mauritius Insulin Biosimilars Market Revenues & Volume, By Premixed biosimilar, 2021- 2031F |
6.2 Mauritius Insulin Biosimilars Market, By Indicative |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Insulin Biosimilars Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.2.3 Mauritius Insulin Biosimilars Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.3 Mauritius Insulin Biosimilars Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Insulin Biosimilars Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Mauritius Insulin Biosimilars Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 Mauritius Insulin Biosimilars Market Revenues & Volume, By Others, 2021- 2031F |
7 Mauritius Insulin Biosimilars Market Import-Export Trade Statistics |
7.1 Mauritius Insulin Biosimilars Market Export to Major Countries |
7.2 Mauritius Insulin Biosimilars Market Imports from Major Countries |
8 Mauritius Insulin Biosimilars Market Key Performance Indicators |
9 Mauritius Insulin Biosimilars Market - Opportunity Assessment |
9.1 Mauritius Insulin Biosimilars Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Mauritius Insulin Biosimilars Market Opportunity Assessment, By Indicative, 2021 & 2031F |
9.3 Mauritius Insulin Biosimilars Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Mauritius Insulin Biosimilars Market - Competitive Landscape |
10.1 Mauritius Insulin Biosimilars Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Insulin Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here